Second Phase 3 Study Supports Hypothesis for LMTM as Monotherapy for Alzheimer’s Disease

November 28, 2017 - Aberdeen, UK – TauRx Therapeutics Ltd reported the full results from its second Phase 3 clinical study of LMTM (registered name: LMTX), the first tau aggregation inhibitor in Alzheimer’s disease, which has been published online in the Journal of Alzheimer’s Disease. More...

November 28, 2017

Severity of Post-Operative Delirium Relates to Severity of Cognitive Decline

November 28, 2017 - Boston, USA – Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research (IFAR), in collaboration with scientists from Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School (HMS), and Brown University, have found increasing evidence that the level of delirium in post-surgical patients is associated with the level of later cognitive decline in those same patients. Findings from this study were published today in the Journal of Alzheimer’s Disease. More...

November 28, 2017

Memory Complaints and Cognitive Decline: Data from the GuidAge Study

November 13, 2017 - Toulouse, France – A new study in the Journal of Alzheimer's Disease by researchers at the Paul Sabatier University in Toulouse identifies a 5-item version of the McNair and Kahn Scale for predicting cognitive decline. More...

November 13, 2017

Journal of Berry Research accepted in Science Citation Index

November 9, 2017 - IOS Press is proud to announce that Journal of Berry Research has been accepted for coverage in the Science Citation Index. More...

November 9, 2017